Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cervical cancer
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-4 of 4 for your search:
Start Over
A Study of INO-3112 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 70
Trial IDs: HPV-004, NCI-2015-00497, NCT02172911
T-cell Receptor Gene Therapy Targeting HPV-16 E6 in Treating Patients with Metastatic, Recurrent, or Refractory HPV-Related Cancer
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 66
Trial IDs: 15-C-0005, NCI-2014-02319, 1407-1331, 337514, P141607, RD-14-VII-09, RD-14-VIII-09, NCT02280811
Vaccine Therapy in Treating Patients with Persistent or Recurrent Cervical Cancer
Status: Temporarily closed
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GOG-0265, NCI-2011-02671, CDR0000691288, NCT01266460
Nivolumab and Synthetic Long E6/E7 Peptides Vaccine HPV-01 in Treating Patients with Recurrent or Metastatic Incurable HPV-16-Positive Solid Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2014-1047, NCI-2015-01004, NCT02426892
Start Over